Target intelligence / Profile preview

Fas associated factor family member 2 (FAF2)

Target
FAF2
Molecular classification
Other (UBX domain-containing protein), Adaptor protein, Endoplasmic reticulum–associated quality control protein
01

Overview

Fas associated factor family member 2 (FAF2) is a multifunctional, UBX domain-containing adaptor protein localized primarily to the endoplasmic reticulum and lipid droplets[2][3]. FAF2 participates in endoplasmic reticulum–associated degradation (ERAD) by interacting with ubiquitin ligase complexes and the segregase p97/VCP to extract misfolded proteins for proteasomal degradation[2][3]. It is also a sensor and regulator of unsaturated fatty acids, modulating triacylglycerol synthesis and lipid droplet formation[2][3]. FAF2 regulates peroxisomal homeostasis, controlling peroxisomal protein abundance—specifically ether lipid synthesis enzymes—upstream of classical peroxin genes, and influences the cellular response to saturated fatty acid toxicity via modulation of pexophagy (selective peroxisome autophagy)[1]. It may play a disease role in atopic dermatitis (where it is upregulated in T cells and eosinophils), metabolic lipotoxicity, and general cellular stress responses[2][3][4]. No approved drugs are currently directed at FAF2, but experimental modulation of autophagy (e.g., by Bafilomycin A1) can alter its functional consequences on peroxisomal and lipid metabolism[1].

Other names
FAS-associated factor 2UBXD8UBXN3BKIAA0887ETEAUBX domain-containing protein 3BUBX domain-containing protein 8UBX domain protein 3BUBX domain containing 8
02

Mechanism of action

Modulation of autophagy/pexophagy (as observed with Bafilomycin A1)[1]

03

Biological functions

Endoplasmic reticulum-associated degradation (ERAD)Lipid homeostasis and lipid droplet regulationRegulation of peroxisomal function and ether lipid synthesisRegulation of apoptosis resistance (especially in immune cells)Stress granule disassemblyRegulation of protein quality control
04

Disease associations

Inflammation (notably atopic dermatitis)Lipotoxicity and metabolic stressOther (potential roles in related ER and lipid metabolism disorders)
05

Safety considerations

Disruption leads to loss of peroxisomal and mitochondrial proteins, altered lipid metabolism, and protection from saturated fatty acid–induced toxicity, which may have relevance for metabolic or degenerative disease models[1]
06

Interacting drugs

Bafilomycin A1
07

Biomarkers

Elevated expression in peripheral blood of patients with atopic dermatitis[2][3][4]

Beyond the preview

Go deeper on Fas associated factor family member 2 (FAF2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fas associated factor family member 2 (FAF2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call